Last updated on February 2018

Belimumab in Myositis

Brief description of study

The goal of the trial is to evaluate the efficacy and safety of belimumab as a maintenance therapy in adults with refractory Idiopathic inflammatory myositis (IIM) as compared with standard of care. This is a multicentre double-blind, placebo-controlled trial.

Clinical Study Identifier: NCT02347891

Contact Investigators or Research Sites near you

Start Over

Todd Levine, MD

Phoenix Neurlogical Associates
Phoenix, AZ United States
  Connect »

Preeya Nandkumar

Northwell Health Divison of Rheumatology
Great Neck, NY United States
  Connect »